VITASPRING BIOMEDICAL CO., LTD. Deferred Tax Assets, Operating Loss Carryforwards
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Deferred Tax Assets, Operating Loss Carryforwards of $1.25 million as of 2026-01-31, per its 10-K filed 2026-06-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-17
- 2026-01-31: Deferred Tax Assets, Operating Loss Carryforwards $1.25M.
- 2025-01-31: Deferred Tax Assets, Operating Loss Carryforwards $1.17M.
- 2024-01-31: Deferred Tax Assets, Operating Loss Carryforwards $1.04M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $865.31K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2026-01-31 | $1.25M 10-K · filed 2026-06-17 |
| 2025-01-31 | $1.17M 10-K · filed 2026-06-17 |
| 2024-01-31 | $1.04M 10-K · filed 2026-06-08 |
| 2023-12-31 | $865.31K 10-K · filed 2025-12-01 |
| 2023-01-31 | $865.31K 10-K · filed 2026-03-12 |
| 2022-12-31 | $0.00 10-K · filed 2025-12-01 |
| 2021-01-31 | $93.93K 10-K · filed 2021-04-14 |
| 2020-10-31 | $21.32K 10-Q · filed 2020-12-15 |
| 2020-01-31 | $4.60K 10-K · filed 2021-04-14 |